Security key
09090D103
BiomX Inc. - Common Stock, par value $0.0001 per share (PHGE)
CUSIP: 09090D103
Q2 2022 13F Holders as of 30 Jun 2022
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Total 13F shares
- 6,178,650
- Total 13F value
- $4,511,000
- Share change
- -436,688
- SEC-reported price per share
- $0.73
- Number of holders
- 10
- Value change
- -$860,141
- Number of buys
- 3
- Number of sells
- 4
- Shares outstanding
- 1,588,808
Holder snapshot
6 signals
Security identity
1 source field
Report period
Q2 2022
Institutions
10
Top holders
10
PHGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2022
Previous quarter: Q1 2022
BiomX Inc. SEC filings
BiomX Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09090D103
Recent filing periods:
Ownership snapshot
Top reported holders of PHGE - BiomX Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ORBIMED ADVISORS LLC
Disclosed value leader
ORBIMED ADVISORS LLC
Comparable rows
12/15
Latest evidence
31 Mar 2022
13F
3/4/5
Lead comparable stake: 177%
3 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
ORBIMED ADVISORS LLC leads the comparable SEC ownership view at 177%.
12 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Comparable ownership
Top 5
ORBIMED ADVISORS LLC
177%
JOHNSON & JOHNSON
134%
MMCAP International Inc. SPC
43%
Kepos Capital LP
28%
ROYCE & ASSOCIATES LP
20%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
177%
|
$5,430,000
2,813,489 shares
|
— | 31 Mar 2022 |
| JOHNSON & JOHNSON |
13F
Company
|
134%
|
$4,117,000
2,133,402 shares
|
— | 31 Mar 2022 |
| MMCAP International Inc. SPC |
13F
Company
|
43%
|
$1,321,000
684,451 shares
|
— | 31 Mar 2022 |
| Kepos Capital LP |
13F
Company
|
28%
|
$870,000
450,597 shares
|
— | 31 Mar 2022 |
| ROYCE & ASSOCIATES LP |
13F
Company
|
20%
|
$619,000
320,655 shares
|
— | 31 Mar 2022 |
| MILLENNIUM MANAGEMENT LLC |
13F
Company
|
6.1%
|
$188,000
97,355 shares
|
— | 31 Mar 2022 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2022
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
6,178,650
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
12
Q2 2022 holders
10
Holder diff
-2
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 value | Q2 2022 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend